HIV RESEARCH CORE

艾滋病毒研究核心

• 批准号: 7960428
• 负责人: Cecilia M. Shikuma
• 金额: $ 40.27万
• 依托单位: UNIVERSITY OF HAWAII AT MANOA
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-07-01 至 2010-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7960428
• 关键词: AIDS neuropathy; Acquired Immunodeficiency Syndrome; Burn injury; Clinical; Clinical Research; Clinical Trials Unit; Clinical and Translational Science Awards; Collaborations; Computer Retrieval of Information on Scientific Projects Database; Development; Education; Funding; Grant; HIV; HIV-1; Hawaii; Hospitals; Human Development; Infection; Institution; Malignant Neoplasms; Neurosciences Research; Patients; Population; Quality of life; Research; Research Infrastructure; Research Personnel; Resources; Services; Source; United States National Institutes of Health; Universities; clinical care; clinically relevant; improved; medical schools; programs

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The UH CRC program has expanded to include a HIV Research Core in affiliation with the Hawaii AIDS Clinical Research Program (HACRP) of the UH John A. Burns School of Medicine. Located at Leahi Hospital, the HACRP emphasizes HIV education, research, and service in accordance with the following specific aims: 1) To develop clinical research capabilities to evaluate optimal therapies for HIV-1 infection and AIDS-associated complications. 2) To provide access to clinical research, trials, and studies for all HIV-1 infected patients in Hawaii. 3) To facilitate the transfer of research findings to clinical care which will ultimately improve the quality of life for patients with HIV-1 infection. THe HACRP also includes the Hawaii AIDS Clinical Trials Unit (HACTU) and the NeuroAIDS Specialized Neuroscience Research Program (NeuroAIDS SNRP). This affiliation with the HACRP is in congruence with the specific aims of the UH CRC program, namely, to build and refine clinical excellence and expertise in Early Human Development, Bionutrition, HIV and Cancer, with particular emphasis on issues of clinical relevance to the populations of the State of Hawaii. Moreover, the development of the HIV Research Core with the HACRP gives evidence of research collaboration and partnership which will further strengthen the University of Hawaii's ability to compete for a NIH institutional Clinical Translational Science Award (CTSA).

该副本是利用众多研究子项目之一 由NIH/NCRR资助的中心赠款提供的资源。子弹和 调查员（PI）可能已经从其他NIH来源获得了主要资金， 因此可以在其他清晰的条目中代表。列出的机构是 对于中心，这不一定是调查员的机构。 UH CRC计划已扩展到与UH John A. Burns医学院的夏威夷艾滋病临床研究计划（HACRP）的隶属关系中包括HIV研究核心。 HACRP位于Leahi医院，根据以下特定目的强调HIV教育，研究和服务： 1）开发临床研究能力，以评估HIV-1感染和与AIDS相关并发症的最佳疗法。 2）为夏威夷所有HIV-1感染患者提供访问临床研究，试验和研究。 3）促进研究结果将其转移到临床护理中，这最终将改善HIV-1感染患者的生活质量。 HACRP还包括夏威夷艾滋病临床试验单元（HACTU）和神经辅助专业的神经科学研究计划（Neuroaids SNRP）。 与HACRP的这种隶属关系与UH CRC计划的具体目的一致，即在早期人类发展，Bionutrientrion，HIV和癌症方面建立和完善临床卓越和专业知识，特别强调与夏威夷州人口的临床相关性问题。 此外，HACRP的艾滋病毒研究核心的发展提供了研究合作和伙伴关系的证据，这将进一步增强夏威夷大学争夺NIH机构临床转化科学奖（CTSA）的能力。